Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA.

Abstract	Two families with a point mutation in mtDNA associated with myoclonic epilepsy and ragged-red fiber disease showed pronounced clinical heterogeneity. The mothers of the two families had adult-onset myopathy with ragged-red fibers, partial deficiency of cytochrome c oxidase, and sensory neuropathy. Members of the first family had variable clinical features of progressive ataxic-myoclonic encephalomyopathy and of the other family, primarily adult-onset myopathy. There was a point mutation from A to G at nucleotide pair 8344 located in the tRNALys gene of the mtDNA of all patients tested, three in Family 1, and the mother of Family 2. This clinical heterogeneity may reflect the effects of varying proportions of mutant and wild-type mtDNA in the different organ systems in each individual.
Authors	W D Graf, S M Sumi, M K Copass, L M Ojemann, W T Longstreth Jr, S Shanske, A Lombes, S DiMauro
Journal	Annals of neurology (Ann Neurol) Vol. 33 Issue 6 Pg. 640-5 (Jun 1993) ISSN: 0364-5134 [Print] United States
PMID	8388680 (Publication Type: Case Reports, Journal Article)
Chemical References	DNA, Mitochondrial Oligodeoxyribonucleotides RNA, Transfer, Lys Guanine Succinate Dehydrogenase NADH Dehydrogenase Electron Transport Complex IV Citrate (si)-Synthase Adenine
Topics	Adenine Adult Base Sequence Biopsy Citrate (si)-Synthase (metabolism) Cytochrome-c Oxidase Deficiency DNA, Mitochondrial (genetics, isolation & purification) Electron Transport Complex IV (metabolism) Family Female Guanine Humans MERRF Syndrome (enzymology, genetics, pathology) Male Middle Aged Mitochondria, Muscle (enzymology) Molecular Sequence Data Muscles (enzymology, pathology) NADH Dehydrogenase (metabolism) Oligodeoxyribonucleotides Pedigree Phenotype Point Mutation Polymerase Chain Reaction (methods) RNA, Transfer, Lys (genetics) Succinate Dehydrogenase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!